LMRI vs CNMD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LMRI · Lumexa Imaging$13.43 ▲ 1.67%
CNMD · ConMed$51.50 ▼ 2.52%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LMRI -27.5%
- CNMD +29.2%
Head to head
| Metric | LMRI | CNMD |
|---|---|---|
| Price | $13.43 | $51.50 |
| Change today | ▲ 1.67% | ▼ 2.52% |
| Market cap | $1.29B | $1.53B |
| Return, 3 months | +14.4% | +4.1% |
| Return, year to date | -27.4% | +26.8% |
| Return, 1 year | – | +17.1% |
| P/E (TTM) | – | 21.4 |
| P/B | 2.1 | 1.4 |
| P/E percentile vs own 5y | 16th | 40th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +5.1% | -0.7% |
| Net profit growth (YoY) | +138.0% | +592.4% |
| Gross margin | 14.9% | 57.6% |
| Operating margin | 1.4% | 9.9% |
| Net margin | -2.7% | 5.4% |
| Return on equity | -4.5% | 7.1% |
| Analyst target vs. price | +27.8% | -3.9% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 76 | 61 |
| 30-day volatility | 53.4% | 55.2% |
| Max drawdown, 1 year | -63.5% | -32.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CNMD is the largest of the group by market value.
- LMRI is growing revenue fastest.
- CNMD keeps the most profit per dollar of sales.
- LMRI has been the calmest stock over the last 30 days.